Orgotein: a new antiinflammatory metalloprotein drug evaluation of clinical efficacy and safety in inflammatory conditions of the urinary tract.
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003556:Cystitis / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008667:Metalloproteins / Q000008:administration & dosage / Q000627:therapeutic use*; D010411:Penile Induration / Q000188:drug therapy; D011472:Prostatitis / Q000188:drug therapy; D006848:Testicular Hydrocele / Q000188:drug therapy / Q000473:pathology; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D008667:Metalloproteins; C005180:orgotein